What NT-proBNP Can Tell Us About TEER Outcomes
Viktor Zarev
New research presented at THT 2026 suggests that the NT-proBNP biomarker could give us a glimpse into which patients with severe tricuspid regurgitation (TR) will benefit the most from transcatheter edge-to-edge repair (TEER).
- NT-proBNP (N-terminal pro-B-type natriuretic peptide) is a key blood biomarker used to diagnose, rule out, and manage heart failure by measuring cardiac stress.
- TEER for severe TR is proven to improve symptoms and reduce heart failure hospitalizations, but predicting..